Pier Capital’s ICU Medical ICUI Stock Holding History

Pier Capital’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-37,291	Closed	-$5.5M	–	117
2016 Q4	$5.5M	Buy	+37,291	New	+$5.4M	0.99%	53

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pier Capital's ICUI Position: Q1 2017 in Review

Pier Capital sold out of ICU Medical (ICUI) in Q1 2017, closing a stake of 37,291 shares — an estimated $5.5M sold.

Pier Capital first reported a position in ICUI in Q4 2016 and held it in 1 quarter. The position peaked at $5.5M in Q4 2016. 230 funds tracked by Wall St. Rank hold ICUI as of Q1 2017.

Pier Capital reported no remaining ICU Medical position as of Q1 2017 after selling out during the quarter.
Pier Capital sold 37,291 ICU Medical shares in Q1 2017, an estimated $5.5M.
Pier Capital first reported a position in ICU Medical in Q4 2016 and held it in 1 quarter.
Pier Capital's ICU Medical position peaked at $5.5M in Q4 2016.
230 funds tracked by Wall St. Rank held ICU Medical as of Q1 2017.

Based on Pier Capital's 13F filing for Q1 2017, filed 10 May 2017.